Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.
about
Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesA phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyPhase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer.Therapeutic options for intrahepatic cholangiocarcinomaSelective hypertrophy of the lobus caudatus as a novel approach enabling extended right hepatectomy in the presence of a non-perfused left lateral liver lobeYttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer.Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Targeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.Emerging pharmacotherapeutic strategies for cholangiocarcinoma.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Cholangiocellular Carcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.[Diagnostics and treatment of cholangiocellular carcinoma].Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection.
P2860
Q30234532-7E7A0ECA-AF5D-4A08-81D5-1245C094D6A0Q30300756-58CE2E48-D7B1-4F0D-8FA0-D117E716F3BFQ33399656-263F75EF-43D9-415F-A884-1E12D26106FEQ33417019-A38C2F0D-31F6-465F-B52F-0048FB069DE2Q33420378-FC503729-D102-4FAD-BFE1-F71DE2EEFBB1Q33621529-013373EF-6379-4067-B094-78E4E6D79663Q34252744-EB42BC9D-2DA8-467E-A916-DD7ADD670724Q34650742-2A1F828E-6516-4FF8-83AF-BE3DA3BD9182Q34982545-5DD959CA-0688-4B05-B1F2-836A4A0C757BQ35179917-10E926B0-3FA4-4644-8D9C-18BDF845FAF9Q35429914-1BF47359-67D4-44C0-A6F7-D53699360168Q36962011-F43FFBA7-AAB0-44C2-ACCB-56DB55E71C07Q37132750-48957980-62A4-4C64-A44A-84AC5412CD58Q37138732-C6F5386F-5C38-4607-AD39-DF3E4C319FC5Q37876403-6AB3CCBD-9B89-4B81-8D94-30D1876AEEE0Q37983498-769F47AD-2150-438C-9A87-C870C709821BQ38746546-A6A0355A-4BE3-4764-8860-C1F52ABAB058Q38812588-42EC8D92-AC10-4803-88A9-FA73D7EA0870Q39008379-1A10C684-7D19-4D57-BE0D-F88689C87743Q39313846-C3B1808E-0C93-4509-AE96-C682D344BCB2Q39662945-07A9B75E-EFC2-416F-B48D-E1DE1D68EB75Q51073522-2B1FBC82-390F-4AF7-B1AB-45E1A5FF4FEAQ55008534-AFA4AC44-D8BE-40C3-8913-10059C3A5B87
P2860
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@ast
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@en
type
label
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@ast
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@en
prefLabel
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@ast
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@en
P2093
P1476
Gemcitabine and oxaliplatin in ...... er Study Group phase II trial.
@en
P2093
Bong Seog Kim
Eunsik Park
Ho Yeong Lim
Hong Suk Song
In Gyu Hwang
Jae Ho Byun
Joung-Soon Jang
Kyung Hee Lee
Myung Ah Lee
NaeChoon Yoo
P2860
P2888
P304
P356
10.1007/S00280-009-1069-7
P577
2009-08-04T00:00:00Z
P6179
1023953779